Abstract:
:Population dynamic models, commonly used tools in the study of epidemics and other complex population processes, are implicit non-linear mathematical equations. Inference based on such models can be difficult due to the problems associated with high dimensional parameters that may be non-identified and complex likelihood functions that are difficult to maximize. To address a problem of non-identifiability due to collinearity of parameter estimates in a mathematical model of the 1993 Milwaukee Cryptosporidium parvum outbreak, we examined the utility of a constrained profile likelihood approach. This method was used to study two parameters of interest from the mathematical model: (i). the rate of secondary transmission; (ii). the proportional increase in primary transmission due to water treatment failure. The estimated values of these parameters were shown to depend strongly on poorly understood aspects of Cryptosporidium epidemiology such as asymptomatic proportion and the population immune status. Our analysis demonstrated that the combination of a disease transmission model and a constrained profile likelihood procedure provides an effective approach for inference and estimation of important parameters regulating infectious disease outbreaks.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Brookhart MA,Hubbard AE,van der Laan MJ,Colford JM Jr,Eisenberg JNdoi
10.1002/sim.1258subject
Has Abstractpub_date
2002-12-15 00:00:00pages
3627-38issue
23eissn
0277-6715issn
1097-0258journal_volume
21pub_type
杂志文章abstract::The Box-Cox power exponential (BCPE) distribution, developed in this paper, provides a model for a dependent variable Y exhibiting both skewness and kurtosis (leptokurtosis or platykurtosis). The distribution is defined by a power transformation Y(nu) having a shifted and scaled (truncated) standard power exponential ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1861
更新日期:2004-10-15 00:00:00
abstract::Korn and Whittemore have presented methods for analyzing longitudinal data where the number of observations per individual is large relative to the number of variables considered for each subject. However, this is often not the case in epidemiologic studies, since one usually collects data at relatively few time point...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780040407
更新日期:1985-10-01 00:00:00
abstract::Both traditional phase I designs and the increasingly popular continual reassessment method (CRM) designs select an estimate of maximum tolerable dose (MTD) from among a set of prespecified dose levels. Although CRM designs use an implied dose-response model to select the next dose level, in general it is neither assu...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.903
更新日期:2001-08-30 00:00:00
abstract::Huntington's disease (HD) is a neurodegenerative disorder with a dominant genetic mode of inheritance caused by an expansion of CAG repeats on chromosome 4. Typically, a longer sequence of CAG repeat length is associated with increased risk of experiencing earlier onset of HD. Previous studies of the association betwe...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5971
更新日期:2014-04-15 00:00:00
abstract::A preference trial is a special form of cross-over trial where clinical conditions determine when patients change treatment, in a prescribed order. This can be modelled using a geometric distribution. The model can be simply fitted using standard logistic regression methodology. The procedure is applied to a trial stu...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(SICI)1097-0258(19960229)15:4<443::AID-SIM
更新日期:1996-02-28 00:00:00
abstract::For robust detection performance, traditional control chart monitoring for biosurveillance is based on input data free of trends, day-of-week effects, and other systematic behaviour. Time series forecasting methods may be used to remove this behaviour by subtracting forecasts from observations to form residuals for al...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2835
更新日期:2007-09-30 00:00:00
abstract::In this paper, we proposed a mechanistic breast cancer survival model based on the axillary lymph node chain structure, considering lymph nodes as a potential dissemination arrangement. We assume a naive breast cancer treatment protocol consisting of exposing patients first to a chemotherapy treatment on r intervals a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5576
更新日期:2013-04-30 00:00:00
abstract::In the analysis of composite endpoints in a clinical trial, time to first event analysis techniques such as the logrank test and Cox proportional hazard test do not take into account the multiplicity, importance, and the severity of events in the composite endpoint. Several generalized pairwise comparison analysis met...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8388
更新日期:2019-12-30 00:00:00
abstract::This paper discusses regression analysis of multivariate current status failure time data (The Statistical Analysis of Interval-censoring Failure Time Data. Springer: New York, 2006), which occur quite often in, for example, tumorigenicity experiments and epidemiologic investigations of the natural history of a diseas...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3715
更新日期:2009-11-30 00:00:00
abstract::A technique is presented which provides guidance on the spacing of follow-up waves in a multiwave study. Only information from the baseline wave is needed, as well as rough parameter estimates for the survival distribution. The computations use the expected Fisher information; a new method for its calculation is given...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780101209
更新日期:1991-12-01 00:00:00
abstract::There is a single-minded focus on events in survival analysis, and we often ignore longitudinal data that are collected together with the event data. This is due to a lack of methodology but also a result of the artificial distinction between survival and longitudinal data analyses. Understanding the dynamics of such ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5324
更新日期:2012-08-15 00:00:00
abstract::In recent years, quality control charts have been increasingly applied in the healthcare environment, for example, to monitor surgical performance. Risk-adjusted cumulative (CUSUM) charts that utilize risk scores like the Parsonnet score to estimate the probability of death of a patient from an operation turn out to b...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8104
更新日期:2019-05-30 00:00:00
abstract::The analysis and recognition of disease clustering in space and its representation on a map is an important problem in epidemiology. An approach using mixture models to identify spatial heterogeneity in disease risk and map construction within an empirical Bayes framework is described. Once heterogeneity is detected, ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19960415)15:7/9<919::aid-s
更新日期:1996-04-15 00:00:00
abstract::The Cardiac Arrythmia Suppression Trial was stopped much earlier than planned. Statistical considerations played a very important role in the decision. Flexible group sequential testing was developed for the trial by implementing a Lan and DeMets procedure with use of the permutation test. We compute P-values from the...
journal_title:Statistics in medicine
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1002/sim.4780090915
更新日期:1990-09-01 00:00:00
abstract::A targeted poll was undertaken to compare and contrast models of data monitoring of randomized clinical trials sponsored by the National Institutes of Health. In an attempt to represent the institutes which conduct clinical trials, twelve individuals were selected and asked to respond to a questionnaire specifically p...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780120520
更新日期:1993-03-01 00:00:00
abstract::To summarize safety data such as clinical adverse experiences in clinical trials with a moderate to long-term follow-up, we may use a measurement which accounts for the potential differences in the follow-up duration between treatment groups. The incidence rate, which uses the total person-time follow-up in a treatmen...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2335
更新日期:2006-04-30 00:00:00
abstract::Longitudinal studies are commonly used to study processes of change. Because data are collected over time, missing data are pervasive in longitudinal studies, and complete ascertainment of all variables is rare. In this paper a new imputation strategy for completing longitudinal data sets is proposed. The proposed met...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.740
更新日期:2001-09-15 00:00:00
abstract::Graphical methods are often used to check goodness-of-fit of models to data. It is common to plot residuals against a reference distribution so that when the model fits the data, the configuration should be close to a straight line. Since the resemblance to a straight line is often unclear, it has been suggested to ad...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780141607
更新日期:1995-08-30 00:00:00
abstract::In this paper, we define a modified version τ(b) of Kendall's tau to measure the association in a pair (X,Y) of random variables subject to fixed left censoring due to known lower detection limits. We provide a nonparametric estimator of τ(b) and investigate its asymptotic properties. We then assume an Archimedean cop...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4319
更新日期:2011-11-20 00:00:00
abstract::In a typical bioequivalence trial, summary measures of the plasma concentration versus time profile are used to compare two formulations of a drug product. Commonly used measures include area under the curve (AUC), maximum plasma concentration (C(max)) and time to maximum concentration (T(max)). Equivalence of these s...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/1097-0258(20001030)19:20<2855::aid-sim550>
更新日期:2000-10-30 00:00:00
abstract::A considerable number of the clinical reports which are presented to the Dutch Board for the Evaluation of Drugs, have deficiencies and/or shortcomings. A number of these, including loose description of the target population and sampling method, methodological flaws, incorrect treatment of withdrawals, confounding of ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780020209
更新日期:1983-04-01 00:00:00
abstract::In the pharmaceutical industry, an assay method is considered validated if the accuracy and precision for an assay meet some acceptable limits. This paper discusses the assessment of assay precision in terms of the estimation of total variability of an assay from a one-way random effects model which is often considere...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780101006
更新日期:1991-10-01 00:00:00
abstract::Girardeau, Ravaud and Donner in 2008 presented a formula for sample size calculations for cluster randomised crossover trials, when the intracluster correlation coefficient, interperiod correlation coefficient and mean cluster size are specified in advance. However, in many randomised trials, the number of clusters is...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8191
更新日期:2019-08-15 00:00:00
abstract::This paper models monthly AIDS diagnosis counts in terms of smooth secular trend, calendar month effects, and the number of workdays per month. A parameterization of month effects allows separation of true seasonal effects from a linear trend over the calendar year and an arbitrary June effect. There is strong evidenc...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780131905
更新日期:1994-10-15 00:00:00
abstract::In population-based case-control studies, an attempt is made to identify all incident cases diagnosed in a specified population during a fixed time interval. Assuming that this goal is met allows one to obtain measures of risk other than relative risks. In this paper, we describe three approaches to estimate exposure-...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780130526
更新日期:1994-03-15 00:00:00
abstract::When analyzing time to disease recurrence, we sometimes need to work with data where all the recurrences are recorded, but no information is available on the possible deaths. This may occur when studying diseases of benign nature where patients are only seen at disease recurrences or in poorly-designed registries of b...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6766
更新日期:2016-03-30 00:00:00
abstract::Statistical methods for testing and interval estimation of the ratio of marginal probabilities in the matched-pair setting are considered in this paper. We are especially interested in the situation where the null value is not one, as in one-sided equivalence trials. We propose a Fieller-type statistic based on constr...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1017
更新日期:2002-03-15 00:00:00
abstract::Machine learning techniques such as classification and regression trees (CART) have been suggested as promising alternatives to logistic regression for the estimation of propensity scores. The authors examined the performance of various CART-based propensity score models using simulated data. Hypothetical studies of v...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3782
更新日期:2010-02-10 00:00:00
abstract::We consider recurrent events of the same type that occur during alternating restraint and non-restraint time periods. This research is motivated by a study on juvenile recidivism, where the probationers were followed for re-offenses during alternating placement periods and free-time periods. During the placement perio...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7150
更新日期:2017-02-20 00:00:00
abstract::Conventional seamless phase 2/3 design with fixed sample size determination (SSD) has gained its popularity in oncology drug development due to attractive features such as significantly shortening the development timeline, minimizing sample size, as well as early decision making. However, this design is not immune to ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8543
更新日期:2020-08-15 00:00:00